Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAGE Sage Therapeutics

未开盘 05-02 16:00:00 EDT

7.30

-0.18

-2.41%

盘后7.48

+0.18+2.47%

19:50 EDT

最高7.63	最低7.26	成交量106.00万
今开7.53	昨收7.48	日振幅4.95%
总市值4.57亿	流通市值3.68亿	总股本6,262万
成交额779.47万	换手率2.10%	流通股本5,040万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAGE","market":"US","secType":"STK","nameCN":"Sage Therapeutics","latestPrice":7.3,"timestamp":1746216000000,"preClose":7.48,"halted":0,"volume":1059963,"hourTrading":{"tag":"盘后","latestPrice":7.48,"preClose":7.3,"latestTime":"19:50 EDT","volume":12095,"amount":88329.12,"timestamp":1746229835655},"delay":0,"floatShares":50402438,"shares":62620694,"eps":-5.791154,"marketStatus":"未开盘","change":-0.18,"latestTime":"05-02 16:00:00 EDT","open":7.53,"high":7.625,"low":7.255,"amount":7794709.271028,"amplitude":0.049465,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.791154,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1405656000000,"exchange":"NASDAQ","adjPreClose":7.48,"preHourTrading":{"tag":"盘前","latestPrice":7.52,"preClose":7.48,"latestTime":"09:29 EDT","volume":559,"amount":4197.920064,"timestamp":1746192599999},"postHourTrading":{"tag":"盘后","latestPrice":7.48,"preClose":7.3,"latestTime":"19:50 EDT","volume":12095,"amount":88329.12,"timestamp":1746229835655},"volumeRatio":1.0088625140866492,"impliedVol":0.4227,"impliedVolPercentile":0.1245},"requestUrl":"/m/hq/s/SAGE/tweets","defaultTab":"tweets","newsList":[{"id":"2513297047","title":"Sage Therapeutics, Inc.盘中异动 临近午盘股价大涨5.03%报7.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513297047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513297047?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:40","pubTimestamp":1740156046,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时40分，Sage Therapeutics, Inc.股票出现波动，股价快速拉升5.03%。截至发稿，该股报7.51美元/股，成交量50.7756万股，换手率0.83%，振幅4.84%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222004046abd7cb7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222004046abd7cb7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2511768670","title":"Sage Therapeutics, Inc.2024财年实现净利润-4.01亿美元，同比增加25.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511768670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511768670?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:00","pubTimestamp":1739635252,"startTime":"0","endTime":"0","summary":"2月16日，Sage Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-4.01亿美元，同比增加25.88%；其中营业收入为41.24百万美元，同比减少52.30%，每股基本收益为-6.59美元。机构评级：截至2025年2月16日，当前有14家机构对Sage Therapeutics, Inc.目标价做出预测，其中目标均价为8.07美元，其中最低目标价为5.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000104a24729bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000104a24729bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE"],"gpt_icon":0},{"id":"2510537254","title":"加拿大投资银行集团：维持Sage Therapeutics(SAGE.US)评级，由持有调整至持有评级, 目标价由9.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510537254","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510537254?lang=zh_cn&edition=full","pubTime":"2025-02-12 21:47","pubTimestamp":1739368053,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Sage Therapeutics(SAGE.US)评级，由持有调整至持有评级, 目标价由9.00美元调整至8.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12214748121630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SAGE","LENZ"],"gpt_icon":0},{"id":"2510769283","title":"Needham：重申Sage Therapeutics(SAGE.US)评级，由持有调整至持有评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510769283","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510769283?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:44","pubTimestamp":1739364291,"startTime":"0","endTime":"0","summary":"Needham：重申Sage Therapeutics(SAGE.US)评级，由持有调整至持有评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12204448120550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SAGE"],"gpt_icon":0},{"id":"2510376162","title":"HC Wainwright & Co.：重申Sage Therapeutics(SAGE.US)评级，由中性调整至中性评级, 目标价由14.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376162","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376162?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:44","pubTimestamp":1739364291,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Sage Therapeutics(SAGE.US)评级，由中性调整至中性评级, 目标价由14.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12204448120545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SAGE"],"gpt_icon":0},{"id":"1166554771","title":"Sage Therapeutics 2024 年第四季度 GAAP 每股收益 $(1.56) 不及预期 $(1.43)，销售额 $12.815M 低于预期 $14.441M","url":"https://stock-news.laohu8.com/highlight/detail?id=1166554771","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166554771?lang=zh_cn&edition=full","pubTime":"2025-02-12 05:12","pubTimestamp":1739308340,"startTime":"0","endTime":"0","summary":"Sage Therapeutics（股票代码：SAGE）2024 年第四季度 GAAP 每股收益为 $(1.56)，低于预期的 $(1.43)。同时，销售额为 $12.815M，不及预期的 $14.441M。以上内容来自Benzinga Earnings专栏，原文如下：$Sage Therapeutics(SAGE)$ Q4 2024 GAAP EPS $(1.56) Misses $(1.43) Estimate, Sales $12.815M Miss $14.441M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sage Therapeutics 2024 年第四季度 GAAP 每股收益 $(1.56) 不及预期 $(1.43)，销售额 $12.815M 低于预期 $14.441M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAGE"],"gpt_icon":0},{"id":"2506303178","title":"Sage Therapeutics, Inc.盘中异动 早盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506303178?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:38","pubTimestamp":1737988698,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时38分，Sage Therapeutics, Inc.股票出现异动，股价急速上涨5.07%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为772.64%、54.50%、43.38%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Onconetix, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为65.16%、54.10%、53.75%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223818a2316c7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223818a2316c7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2505420533","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.08%报6.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505420533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505420533?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:11","pubTimestamp":1737475899,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时11分，Sage Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.65%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为749.75%、465.96%、181.80%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001139abb35d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001139abb35d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2504917567","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504917567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504917567?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:41","pubTimestamp":1737045697,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时41分，Sage Therapeutics, Inc.股票出现异动，股价大幅跳水5.10%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为1840.60%、511.47%、372.53%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为131.33%、104.84%、76.46%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117004138a2247dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117004138a2247dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"1175027291","title":"美股制药巨头并购热潮再起！SAGE涨超36%、ITCI涨超34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175027291","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175027291?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:47","pubTimestamp":1736779628,"startTime":"0","endTime":"0","summary":"1月13日，美股制药巨头并购热潮再起！Sage盘前涨超32%，美国制药商百健上周五宣布拟溢价30%收购剩余股份；Intra-Cellular Therapies盘前续涨超21%，该股上周五大涨近15%，消息称$强生(JNJ)$公司正洽谈对其进行收购。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITCI","SAGE"],"gpt_icon":0},{"id":"2503915588","title":"Sage Therapeutics, Inc.盘中异动 急速拉升38.02%报7.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503915588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503915588?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778717,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Sage Therapeutics, Inc.股票出现波动，股价急速上涨38.02%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2526.83%、1574.23%、389.46%，振幅较大的相关个股有Scinai Immunotherapeutics Ltd、Third Harmonic Bio, Inc.、Abivax，振幅分别为101.42%、100.48%、100.00%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223157a2203ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223157a2203ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2502271808","title":"百健拟溢价30%收购Sage剩余股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2502271808","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502271808?lang=zh_cn&edition=full","pubTime":"2025-01-11 13:54","pubTimestamp":1736574891,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国制药商百健周五宣布，将以每股7.22美元的价格收购其尚未持有的Sage Therapeutics流通股，推动后者股价在美股盘后交易中上涨34%。监管文件显示，百健拥有Sage Therapeutics 10.2%的股份。此次报价较Sage Therapeutics周五收盘价有30%的溢价，对Sage的估值为4.417亿美元。由于对成本、疗效和副作用的担忧，百健的阿尔茨海默病药物Leqembi在美国的销售一直在缓慢回升。Sage股价在2024年暴跌75%。去年7月，Sage还放弃了与百健合作开发的另一种神经系统疾病药物。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1236418.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"百健拟溢价30%收购Sage剩余股份","news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BIIB","BK4533","BK4588","IE00B894F039.SGD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","SAGE","LU0889565916.HKD","LU0109394709.USD","BK4585","LU0234570918.USD","BK4532"],"gpt_icon":0},{"id":"1166667751","title":"Biogen拟以4.42亿美元收购创新药公司Sage剩余股份，Sage盘后涨近44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166667751","media":"老虎资讯综合","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166667751?lang=zh_cn&edition=full","pubTime":"2025-01-11 08:31","pubTimestamp":1736555477,"startTime":"0","endTime":"0","summary":"1月11日，美国药企Biogen将以每股7.22美元的价格收购创新药公司$Sage Therapeutics(SAGE)$ 的所有流通股。根据这份文件，Biogen持有 Sage $Therapeutics(LENZ)$公司10.2%的股份。根据路透的计算，Sage的股权价值为4.417亿美元。受此消息影响，Sage盘后涨近44%。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Biogen拟以4.42亿美元收购创新药公司Sage剩余股份","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","SAGE"],"gpt_icon":0},{"id":"2502985678","title":"Sage Therapeutics, Inc.盘中异动 早盘大幅下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502985678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502985678?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:35","pubTimestamp":1736519748,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时35分，Sage Therapeutics, Inc.股票出现异动，股价急速跳水5.13%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为998.08%、145.35%、144.91%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.，振幅分别为30.12%、22.88%、22.22%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223549aba603e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223549aba603e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2501789651","title":"Sage Therapeutics, Inc.盘中异动 快速上涨5.14%报6.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501789651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501789651?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:51","pubTimestamp":1736261483,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时51分，Sage Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Hoth Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Nrx Pharmaceuticals, Inc.涨幅较大，Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为1228.06%、190.34%、113.44%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Immuneering Corporation，振幅分别为56.12%、49.64%、39.83%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010722512395fba21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010722512395fba21c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2501265638","title":"Sage Therapeutics, Inc.盘中异动 下午盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501265638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501265638?lang=zh_cn&edition=full","pubTime":"2025-01-07 02:27","pubTimestamp":1736188052,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时27分，Sage Therapeutics, Inc.股票出现波动，股价急速拉升5.05%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Scisparc Ltd.、Unity Biotechnology, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1661.19%、378.87%、167.35%，振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为176.15%、106.67%、92.16%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010702273395fa9cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010702273395fa9cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2500975696","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.89%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500975696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500975696?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:13","pubTimestamp":1735830804,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时13分，Sage Therapeutics, Inc.股票出现波动，股价大幅上涨5.89%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Revelation Biosciences, Inc.、知临集团、Onconetix, Inc.较为活跃，换手率分别为1040.99%、64.03%、43.85%，振幅较大的相关个股有Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为121.48%、98.57%、78.14%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231324985905ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102231324985905ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0},{"id":"2494608384","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494608384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494608384?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:31","pubTimestamp":1735313489,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时31分，Sage Therapeutics, Inc.股票出现波动，股价大幅下挫5.06%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Galectin Therapeutics Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Abpro Holdings, Inc涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为102.94%、45.29%、20.44%，振幅较大的相关个股有Galectin Therapeutics Inc.、Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为65.39%、62.45%、58.33%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233129a20c0b56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233129a20c0b56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0},{"id":"2494898854","title":"Sage Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494898854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494898854?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:54","pubTimestamp":1735232068,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日00时54分，Sage Therapeutics, Inc.股票出现异动，股价大幅上涨5.66%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Moolec Science Sa C/Wts 、Scisparc Ltd.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为1951.80%、433.62%、114.83%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Scisparc Ltd.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为264.57%、198.24%、131.78%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227005428a20ab341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227005428a20ab341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0},{"id":"2493080855","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493080855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493080855?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:48","pubTimestamp":1735051680,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时48分，Sage Therapeutics, Inc.股票出现波动，股价大幅下跌5.06%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Clearmind Medicine Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、180 Life Sciences Corp.、Theriva Biologics, Inc.较为活跃，换手率分别为995.81%、578.69%、117.46%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为40.00%、37.88%、35.26%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422480095eb2830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422480095eb2830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagerx.com","stockEarnings":[{"period":"1week","weight":-0.0629},{"period":"1month","weight":-0.0605},{"period":"3month","weight":0.0069},{"period":"6month","weight":0.2066},{"period":"1year","weight":-0.443},{"period":"ytd","weight":0.3444}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司，其使命是开拓解决方案，提供改变生命的大脑健康药物，让每个人都能茁壮成长。除了产后抑郁症商业产品外，该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司，该公司专注于大脑健康，目前他们的目标是两个关键的中枢神经系统受体系统，GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质，通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.065282},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.018867},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.030107},{"month":4,"riseRate":0.545455,"avgChangeRate":0.033437},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.008789},{"month":6,"riseRate":0.5,"avgChangeRate":0.012627},{"month":7,"riseRate":0.5,"avgChangeRate":-0.009867},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.042534},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.036732},{"month":10,"riseRate":0.363636,"avgChangeRate":0.008484},{"month":11,"riseRate":0.636364,"avgChangeRate":0.056493},{"month":12,"riseRate":0.545455,"avgChangeRate":0.048235}],"exchange":"NASDAQ","name":"Sage Therapeutics","nameEN":"Sage Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sage Therapeutics,SAGE,Sage Therapeutics股票,Sage Therapeutics股票老虎,Sage Therapeutics股票老虎国际,Sage Therapeutics行情,Sage Therapeutics股票行情,Sage Therapeutics股价,Sage Therapeutics股市,Sage Therapeutics股票价格,Sage Therapeutics股票交易,Sage Therapeutics股票购买,Sage Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}